vs
BROADWIND, INC.（BWEN）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
BROADWIND, INC.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.1倍（$37.7M vs $35.5M），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 12.4%），BROADWIND, INC.自由现金流更多（$-187.0K vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 0.2%）
Broadwind Inc.是一家总部位于美国的工业制造企业，主营重型结构部件、齿轮系统的生产及相关售后服务，业务覆盖可再生能源、基础设施与重工业领域，主要为北美市场的风电项目、公用事业能源工程等供应核心零部件。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
BWEN vs RXRX — 直观对比
营收规模更大
BWEN
是对方的1.1倍
$35.5M
营收增速更快
RXRX
高出669.3%
12.4%
自由现金流更多
BWEN
多$47.1M
$-47.3M
两年增速更快
RXRX
近两年复合增速
0.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $37.7M | $35.5M |
| 净利润 | — | $-108.1M |
| 毛利率 | 8.8% | 59.8% |
| 营业利润率 | -0.2% | -304.8% |
| 净利率 | — | -304.2% |
| 营收同比 | 12.4% | 681.7% |
| 净利润同比 | — | 39.6% |
| 每股收益（稀释后） | $-0.03 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BWENRXRX
| Q4 25 | $37.7M | $35.5M | ||
| Q3 25 | $44.2M | $5.2M | ||
| Q2 25 | $39.2M | $19.2M | ||
| Q1 25 | $36.8M | $14.7M | ||
| Q4 24 | $33.6M | $4.5M | ||
| Q3 24 | $35.5M | $26.1M | ||
| Q2 24 | $36.5M | $14.4M | ||
| Q1 24 | $37.6M | $13.8M |
净利润BWENRXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $7.5M | $-162.3M | ||
| Q2 25 | $-989.0K | $-171.9M | ||
| Q1 25 | $-370.0K | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | $74.0K | $-95.8M | ||
| Q2 24 | $482.0K | $-97.5M | ||
| Q1 24 | $1.5M | $-91.4M |
毛利率BWENRXRX
| Q4 25 | 8.8% | 59.8% | ||
| Q3 25 | 10.2% | -183.8% | ||
| Q2 25 | 10.1% | -4.9% | ||
| Q1 25 | 11.7% | -48.0% | ||
| Q4 24 | 11.3% | -181.4% | ||
| Q3 24 | 14.6% | 53.7% | ||
| Q2 24 | 15.3% | 36.2% | ||
| Q1 24 | 17.6% | 19.1% |
营业利润率BWENRXRX
| Q4 25 | -0.2% | -304.8% | ||
| Q3 25 | 19.7% | -3327.6% | ||
| Q2 25 | -0.4% | -916.8% | ||
| Q1 25 | 0.5% | -1297.9% | ||
| Q4 24 | -0.9% | -4042.4% | ||
| Q3 24 | 3.3% | -377.1% | ||
| Q2 24 | 3.4% | -697.4% | ||
| Q1 24 | 5.5% | -698.4% |
净利率BWENRXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | 16.9% | -3135.3% | ||
| Q2 25 | -2.5% | -894.2% | ||
| Q1 25 | -1.0% | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | 0.2% | -367.5% | ||
| Q2 24 | 1.3% | -676.6% | ||
| Q1 24 | 4.0% | -662.4% |
每股收益（稀释后）BWENRXRX
| Q4 25 | $-0.03 | $-0.17 | ||
| Q3 25 | $0.32 | $-0.36 | ||
| Q2 25 | $-0.04 | $-0.41 | ||
| Q1 25 | $-0.02 | $-0.50 | ||
| Q4 24 | $-0.04 | $-0.56 | ||
| Q3 24 | $0.00 | $-0.34 | ||
| Q2 24 | $0.02 | $-0.40 | ||
| Q1 24 | $0.07 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $456.0K | $743.3M |
| 总债务越低越好 | $10.1M | $9.6M |
| 股东权益账面价值 | $66.3M | $1.1B |
| 总资产 | $116.8M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.15× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资BWENRXRX
| Q4 25 | $456.0K | $743.3M | ||
| Q3 25 | $1.2M | $659.8M | ||
| Q2 25 | $1.0M | $525.1M | ||
| Q1 25 | $1.2M | $500.5M | ||
| Q4 24 | $7.7M | $594.4M | ||
| Q3 24 | $1.4M | $427.6M | ||
| Q2 24 | $938.0K | $474.3M | ||
| Q1 24 | $1.1M | $296.3M |
总债务BWENRXRX
| Q4 25 | $10.1M | $9.6M | ||
| Q3 25 | $10.3M | $11.9M | ||
| Q2 25 | $26.1M | $14.2M | ||
| Q1 25 | $12.2M | $16.4M | ||
| Q4 24 | $9.2M | $19.0M | ||
| Q3 24 | $16.9M | $20.5M | ||
| Q2 24 | $18.0M | $22.9M | ||
| Q1 24 | $7.7M | — |
股东权益BWENRXRX
| Q4 25 | $66.3M | $1.1B | ||
| Q3 25 | $66.9M | $1.0B | ||
| Q2 25 | $59.0M | $919.1M | ||
| Q1 25 | $59.3M | $933.9M | ||
| Q4 24 | $59.4M | $1.0B | ||
| Q3 24 | $59.6M | $524.6M | ||
| Q2 24 | $59.1M | $584.4M | ||
| Q1 24 | $58.0M | $401.2M |
总资产BWENRXRX
| Q4 25 | $116.8M | $1.5B | ||
| Q3 25 | $119.6M | $1.4B | ||
| Q2 25 | $130.5M | $1.3B | ||
| Q1 25 | $129.3M | $1.3B | ||
| Q4 24 | $128.3M | $1.4B | ||
| Q3 24 | $125.1M | $726.5M | ||
| Q2 24 | $122.5M | $775.9M | ||
| Q1 24 | $123.1M | $557.8M |
负债/权益比BWENRXRX
| Q4 25 | 0.15× | 0.01× | ||
| Q3 25 | 0.15× | 0.01× | ||
| Q2 25 | 0.44× | 0.02× | ||
| Q1 25 | 0.21× | 0.02× | ||
| Q4 24 | 0.15× | 0.02× | ||
| Q3 24 | 0.28× | 0.04× | ||
| Q2 24 | 0.30× | 0.04× | ||
| Q1 24 | 0.13× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $857.0K | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-187.0K | $-47.3M |
| 自由现金流率自由现金流/营收 | -0.5% | -133.1% |
| 资本支出强度资本支出/营收 | 2.8% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-19.0M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流BWENRXRX
| Q4 25 | $857.0K | $-46.1M | ||
| Q3 25 | $4.3M | $-117.4M | ||
| Q2 25 | $-12.5M | $-76.4M | ||
| Q1 25 | $-8.0M | $-132.0M | ||
| Q4 24 | $14.8M | $-115.4M | ||
| Q3 24 | $2.4M | $-59.2M | ||
| Q2 24 | $-9.3M | $-82.2M | ||
| Q1 24 | $5.9M | $-102.3M |
自由现金流BWENRXRX
| Q4 25 | $-187.0K | $-47.3M | ||
| Q3 25 | $3.8M | $-117.6M | ||
| Q2 25 | $-13.7M | $-79.6M | ||
| Q1 25 | $-9.0M | $-133.8M | ||
| Q4 24 | $14.5M | $-116.7M | ||
| Q3 24 | $1.7M | $-63.8M | ||
| Q2 24 | $-10.1M | $-83.4M | ||
| Q1 24 | $4.1M | $-109.0M |
自由现金流率BWENRXRX
| Q4 25 | -0.5% | -133.1% | ||
| Q3 25 | 8.6% | -2272.5% | ||
| Q2 25 | -34.8% | -413.9% | ||
| Q1 25 | -24.3% | -907.4% | ||
| Q4 24 | 43.1% | -2567.7% | ||
| Q3 24 | 4.8% | -244.6% | ||
| Q2 24 | -27.6% | -578.5% | ||
| Q1 24 | 10.9% | -789.9% |
资本支出强度BWENRXRX
| Q4 25 | 2.8% | 3.5% | ||
| Q3 25 | 1.1% | 4.7% | ||
| Q2 25 | 3.1% | 16.4% | ||
| Q1 25 | 2.5% | 12.4% | ||
| Q4 24 | 1.0% | 28.6% | ||
| Q3 24 | 2.1% | 17.5% | ||
| Q2 24 | 2.2% | 8.2% | ||
| Q1 24 | 4.6% | 48.2% |
现金转化率BWENRXRX
| Q4 25 | — | — | ||
| Q3 25 | 0.57× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 32.99× | — | ||
| Q2 24 | -19.26× | — | ||
| Q1 24 | 3.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BWEN
| Heavy Fabrications | $21.6M | 57% |
| Industrial Solutions | $9.4M | 25% |
| Gearing | $7.0M | 19% |
RXRX
暂无分部数据
